Scientific reports · 2026
Identification and verification of SPP1 in anoikis as a prognostic biomarker for intestinal metaplasia and gastric cancer.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Wu Kairui, Ye Yu, Pei Bei, Song Biao, Zhang Yi, Li Tingting, Yang Qi, Jin Yueping, Cheng Hongliang, Li Xuejun
Аннотация
Anoikis is a form of apoptosis induced by cell detachment from the extracellular matrix, and cancer cells must evade it to metastasize. Gastric cancer (GC) remains a leading global cause of cancer-related mortality, with intestinal metaplasia (IM) established as a key premalignant lesion. This study explored the multi-omics features of the anoikis-related gene SPP1 across the control-IM-GC cascade, focusing on its links to immunity and prognosis. Comprehensive transcriptome analyses were conducted using datasets from The Cancer Genome Atlas (TCGA), the Gene Expression Omnibus (GEO), and the GeneCards database via the R programming language. By integrating Weighted Gene Co-expression Network Analysis (WGCNA) and competing endogenous RNA (ceRNA) networks, alongside Gene Set Variation Analysis (GSVA) and Gene Set Enrichment Analysis (GSEA), the study explored the immunological roles of Secreted Phosphoprotein 1 (SPP1) in GC. Furthermore, immune infiltration and immune checkpoint analyses were combined with single-cell RNA sequencing (scRNA-seq) to elucidate the tumor microenvironment. Finally, Cox proportional hazards regression and Receiver Operating Characteristic (ROC) curve analyses were utilized to assess the prognostic significance of SPP1 and to construct a predictive risk signature. RT-qPCR/Western blot (32 human tissues) and in vitro assays were conducted to validate SPP1's expression and function. SPP1 was significantly upregulated across the Correa cascade, with high predictive accuracy, and was associated with survival and potential immunotherapy relevance. Higher levels were associated with a poorer prognosis. In vitro, SPP1 inhibition reduced GC cell migration, enhanced apoptosis, and induced S/G2 phase arrest. To our knowledge, this is the first study to associate SPP1 with IM/GC. Our findings suggest that it may serve as a prognostic biomarker, with immunotherapeutic implications that require further study.